These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27095287)

  • 41. Expression of β-tubulin isotypes in classical Hodgkin's lymphoma.
    Choi JW; Lee JH; Kim YS
    Pathol Int; 2012 Apr; 62(4):287-90. PubMed ID: 22449234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
    Schmidt A; Schmitz R; Giefing M; Martin-Subero JI; Gesk S; Vater I; Massow A; Maggio E; Schneider M; Hansmann ML; Siebert R; Küppers R
    Genes Chromosomes Cancer; 2010 Sep; 49(9):803-9. PubMed ID: 20607853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of immunoglobulin heavy chain gene rearrangements in classic hodgkin lymphoma using commercially available BIOMED-2 primers.
    Chute DJ; Cousar JB; Mahadevan MS; Siegrist KA; Silverman LM; Stoler MH
    Diagn Mol Pathol; 2008 Jun; 17(2):65-72. PubMed ID: 18382369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Expression of CD137 in tumor cells of Hodgkin lymphoma from Northern China and its application in pathological differential diagnosis].
    Shi YF; Gao ZF; Liu CL; Huang X; Song YQ; Zhang C; Lin DM; Zhou LX; Zhao M; Lai YM; Li M
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):484-90. PubMed ID: 27431073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classical Hodgkin Lymphoma With Aberrant CD8 Expression: A Clinicopathologic Study of Five Cases.
    Mirzamani N; Zhang X; Brody J; Spitzer SG; Sen F; Hsu P
    Int J Surg Pathol; 2019 Apr; 27(2):166-173. PubMed ID: 30058423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imbalance of Pro- and Anti-Inflammatory Cytokines in Patients With cHL Persists Despite Treatment Compared With Control Subjects.
    da Silva PB; Perini GF; Pereira Lde A; Sacconato EM; Penna AM; Garibaldi J; Cavalcante E; Baiocchi OC
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S151-7. PubMed ID: 26297269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Classical Hodgkin lymphoma occurring in clusters of nodal marginal zone B-lymphocytes in association with progressive transformation of germinal center. A case report.
    Kojima M; Nakamura S; Shimizu K; Tanaka H; Yamane Y; Sugihara S; Masawa N
    Pathol Res Pract; 2003; 199(8):547-50. PubMed ID: 14533939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells.
    Aldinucci D; Poletto D; Gloghini A; Nanni P; Degan M; Perin T; Ceolin P; Rossi FM; Gattei V; Carbone A; Pinto A
    Am J Pathol; 2002 Feb; 160(2):585-96. PubMed ID: 11839579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histological study of Hodgkin disease (HD), an immunohistochemical identification of the cells surrounding Sternberg-Reed cells.
    Mihailovici MS; Scripcaru D; Butcovan D; Teleman S
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(1-2):135-43. PubMed ID: 10756742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.
    Kadin ME; Agnarsson BA; Ellingsworth LR; Newcom SR
    Am J Pathol; 1990 Jun; 136(6):1209-14. PubMed ID: 2356855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
    Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
    Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma are highly dependent on oxidative phosphorylation.
    Birkenmeier K; Dröse S; Wittig I; Winkelmann R; Käfer V; Döring C; Hartmann S; Wenz T; Reichert AS; Brandt U; Hansmann ML
    Int J Cancer; 2016 May; 138(9):2231-46. PubMed ID: 26595876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
    Bohle V; Döring C; Hansmann ML; Küppers R
    Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases.
    Laurent C; Do C; Gourraud PA; de Paiva GR; Valmary S; Brousset P
    Medicine (Baltimore); 2015 Jun; 94(25):e987. PubMed ID: 26107683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphomagenesis in Hodgkin lymphoma.
    Matsuki E; Younes A
    Semin Cancer Biol; 2015 Oct; 34():14-21. PubMed ID: 25725205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease.
    Kadin M; Butmarc J; Elovic A; Wong D
    Am J Pathol; 1993 Jan; 142(1):11-6. PubMed ID: 8424449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin 13: a growth factor in hodgkin lymphoma.
    Skinnider BF; Kapp U; Mak TW
    Int Arch Allergy Immunol; 2001 Dec; 126(4):267-76. PubMed ID: 11815733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
    Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
    Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.